Clinical significance of combined use of macrophage colony-stimulating factor and squamous cell carcinoma antigen as a selective diagnostic marker for squamous cell carcinoma arising in mature cystic teratoma of the ovary

Gynecologic Oncology

Volumn 77, Issue 3, 2000, Pages 405-409

  Suzuki, Mitsuaki ^a   Tamura, Natsuko ^a   Kobayashi, Hiroshi ^b   Ohwada, Michitaka ^a   Terao, Toshihiko ^b   Sato, Ikuo ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Macrophage colony stimulating factor; Squamous cell carcinoma antigen; Squamous cell carcinoma arising in mature cystic teratoma of the ovary; Tumor marker

Indexed keywords

COLONY STIMULATING FACTOR 1; SQUAMOUS CELL CARCINOMA ANTIGEN; TUMOR MARKER;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CANCER DIAGNOSIS; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALIGNANT TRANSFORMATION; OVARY CARCINOMA; OVARY TERATOMA; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

EID: 0034091525     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.2000.5784     Document Type: Article

References (19)

1. Peterson W F, Prevost E C, Edmunds F T, Hundley J M Jr, Morris F K. Benign cystic teratomas of the ovary: A clinico-statistical study of 1,007 cases with a review of the literature. Am J Obstet Gynecol. 70:1955;368-382.
2. Matz M H. Benign cystic teratomas of the ovary. Obstet Gynecol Surv. 16:1961;591-605.
3. Peterson W F. Malignant degeneration of benign cystic teratomas of the ovary: A collective review of the literature. Obstet Gynecol Surv. 12:1957;793-830.
4. Caruso P A, Marsh M R, Minkowitz S, Karten G. An intense clinicopathologic study of 305 teratomas of the ovary. Cancer. 27:1971;343-348.
5. Pantoja E, Rodriguez-Ibanez I, Axtmayer R W, Noy F MA, Pelegrina I. Complications of dermoid tumors of the ovary. Obstet Gynecol. 45:1975;89-94.
6. Krumerman M S, Chung A. Squamous carcinoma arising in benign cystic teratoma of the ovary: A report of four cases and review of the literature. Cancer. 39:1977;1237-1242.
7. Suzuki M, Ohwada M, Aida I, Tamada T, Hanamura T, Nagatomo M. Macrophage colony-stimulating factor as a tumor marker for epithelial ovarian cancer. Obstet Gynecol. 82:1993;946-950.
8. Suzuki M, Ohwada M, Sato I, Nagatomo M. Serum level of macrophage colony-stimulating factor as a marker for gynecologic malignancies. Oncology. 52:1995;128-133.
9. Suzuki M, Kobayashi H, Ohwada M, Terao T, Sato I. Macrophage colony-stimulating factor as a marker for malignant germ cell tumors of the ovary. Gynecol Oncol. 68:1998;35-37.
10. Kato H, Torigoe T. Radioimmunoassay for tumor antigen of human cervical squamous cell carcinoma. Cancer. 40:1977;1621-1628.
11. Kimura T, Inoue M, Miyake A, Tanizawa O, Oka Y, Amemiya K, Mineta H, Neki R, Nishino H, Morishige K, Yanagida T. The use of serum TA-4 in monitoring patients with malignant transformation of ovarian mature cystic teratoma. Cancer. 64:1989;480-483.
12. Miyazaki K, Tokunaga T, Katabuchi H, Ohba T, Tashiro H, Okamura H. Clinical usefulness of serum squamous cell carcinoma antigen for early detection of squamous cell carcinoma arising in mature cystic teratoma of the ovary. Obstet Gynecol. 78:1991;562-566.
13. Suzuki M, Kobayashi H, Sekiguchi I, Konnai K, Terao T, Sato I. Clinical evaluation of squamous cell carcinoma antigen in squamous cell carcinoma arising in mature cystic teratoma of the ovary. Oncology. 52:1995;287-290.
14. Hanamura T, Motoyoshi K, Yoshida K, Saito M, Miura Y, Kawashima T, Nishida M, Takaku F. Quantitation and identification of human monocytic colony-stimulating factor in human serum by enzyme-linked immunosorbent assay. Blood. 72:1988;886-892.
15. Torigoe T, Takeuchi S, Sugawa T, Takamizawa H, Hashimoto M, Shinagawa N, Nishiya I, Ishii M, Kato K, Kasamatsu T, Yamada T, Masubuchi K. The clinical application of squamous cell carcinoma-associated antigen, TA-4, R1A kit. Obstet Gynecol (Tokyo). 51:1984;1199-1207.
16. Del Villano B C, Brennan S, Brock P, Bucker C, Liu V, McClure M, Rake B, Space S, Westrick B, Schoemaker H, Zurawski V R Jr. Radioimmunometric assay for a monoclonal antibody-defined tumor marker, CA19-9. Clin Chem. 29:1983;549-552.
17. Bast R C Jr, Klug T L, John E RN, Jenison E, Niloff J M, Lazarus H, Berkowitz R S, Leavitt T, Griffiths T, Parker L, Zurawski V R Jr, Knapp R C. A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. N Engl J Med. 309:1983;883-887.
18. Sakurabayashi I, Kawai T, Suzuki M, Tamada T, Sato K, Yonezawa M. Clinical evaluation of a cancer antigen, CA 125, associated with ovarian cancer. I. Technical investigation and the reference value. Rinsho Byori. 32:1984;1345-1349.
19. Crombach G, Scharl A, Vierbuchen M, Wurz H, Bolte A. Detection of squamous cell carcinoma antigen in normal squamous epithelia and in squamous cell carcinoma of the uterine cervix. Cancer. 63:1989;1337-1342.